SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $347,000 | -84.9% | 60,000 | -84.2% | 0.00% | -83.3% |
| Q1 2016 | $2,297,000 | +23.3% | 379,727 | +86.8% | 0.01% | +20.0% |
| Q4 2015 | $1,863,000 | +57.7% | 203,259 | -1.6% | 0.01% | +66.7% |
| Q3 2015 | $1,181,000 | +788.0% | 206,517 | +5041.1% | 0.00% | – |
| Q2 2015 | $133,000 | -98.6% | 4,017 | -99.3% | 0.00% | -100.0% |
| Q1 2015 | $9,741,000 | -0.7% | 563,797 | 0.0% | 0.02% | -4.2% |
| Q4 2014 | $9,807,000 | +53.1% | 563,797 | +4.3% | 0.02% | +50.0% |
| Q3 2014 | $6,405,000 | -29.4% | 540,380 | +0.3% | 0.02% | -27.3% |
| Q2 2014 | $9,066,000 | +25.4% | 538,880 | +34.7% | 0.02% | +15.8% |
| Q1 2014 | $7,232,000 | -38.6% | 400,000 | -52.8% | 0.02% | -40.6% |
| Q4 2013 | $11,772,000 | +32.5% | 847,550 | 0.0% | 0.03% | +23.1% |
| Q3 2013 | $8,882,000 | +168.0% | 847,550 | +99.7% | 0.03% | +160.0% |
| Q2 2013 | $3,314,000 | – | 424,350 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |